Abingdon Health key partner in consortium to develop UK COVID-19 Antibody Test

YORK, U.K. - April 9, 2020 - PRLog -- York based rapid test developer and manufacturer, Abingdon Health, has announced its membership of the consortium of top UK diagnostic companies to deliver a new COVID-19 antibody rapid test.

The UK Rapid Test Consortium (UK-RTC), which comprises the University of Oxford, Abingdon Health, Omega Diagnostics, BBI Solutions and CIGA Healthcare, has been launched to develop and manufacture millions of new COVID-19 antibody tests to determine someone's immunity after contracting the virus.

UK-RTC was formed in response to UK Government's request to develop a 'home-grown test' following validation of existing antibody tests that 'have not proven accurate enough'.

The UK Government is scaling-up COVID-19 testing as part of its National Testing Strategy and consortiums such as UK-RTC will play an important role in their ambition for accurate testing, focusing on frontline and essential workers before deploying the tests to the wider population.

UK-RTC will utilise Abingdon Health's lateral flow rapid test development and manufacturing ...

Full press release at https://www.abingdonhealth.com/abingdon-health-key-partner-in-consortium-to-develop-a-uk-antibody-test/